Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
41.90
+0.45 (1.09%)
Feb 3, 2026, 3:00 PM CST

SHA:600211 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
13,36011,90612,0998,90612,98216,681
Market Cap Growth
13.56%-1.59%35.86%-31.40%-22.18%194.44%
Enterprise Value
11,4469,88010,3697,66212,46716,027
Last Close Price
41.4535.2934.3324.3835.2244.78
PE Ratio
13.6311.3315.1124.0862.1339.90
Forward PE
-26.4826.4826.4826.4826.48
PS Ratio
4.914.243.863.496.0712.15
PB Ratio
3.393.013.592.944.916.45
P/TBV Ratio
4.253.203.863.445.8810.27
P/FCF Ratio
14.4312.4411.6212.11-80.63
P/OCF Ratio
13.9111.9711.3810.6435.4238.96
EV/Sales Ratio
4.213.523.313.005.8311.67
EV/EBITDA Ratio
12.9510.219.3710.1219.0633.05
EV/EBIT Ratio
14.2311.069.9811.1321.7739.35
EV/FCF Ratio
12.3610.329.9510.42-77.47
Debt / Equity Ratio
0.250.070.150.160.200.00
Debt / EBITDA Ratio
1.090.280.450.640.820.02
Debt / FCF Ratio
1.050.290.480.66-0.05
Asset Turnover
0.520.600.720.650.630.48
Inventory Turnover
1.171.321.501.732.172.69
Quick Ratio
2.834.402.742.511.763.82
Current Ratio
3.024.662.872.641.974.06
Return on Equity (ROE)
25.98%28.86%25.30%13.23%8.14%16.71%
Return on Assets (ROA)
9.59%11.96%14.95%10.89%10.61%8.91%
Return on Invested Capital (ROIC)
42.03%52.87%60.70%32.15%25.90%21.17%
Return on Capital Employed (ROCE)
18.10%22.40%30.50%22.40%21.30%15.60%
Earnings Yield
7.34%8.83%6.62%4.15%1.61%2.51%
FCF Yield
6.93%8.04%8.61%8.26%-0.46%1.24%
Dividend Yield
4.41%5.55%4.34%2.35%0.74%0.88%
Payout Ratio
60.75%47.03%61.74%26.55%63.41%45.16%
Buyback Yield / Dilution
-0.13%0.14%-0.09%0.21%-0.53%0.98%
Total Shareholder Return
4.28%5.69%4.26%2.56%0.20%1.85%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.